Because of elevated frequency of Tc17 in relapse patients, we measured the relative quantity of TGF-β, IL-6 and IL-23, cytokines involved in Tc17 cells development, in sera from RRMS, SPMS and PPMS patients as well as sex and age-matched healthy control group. The gene discussed is TGFB1; the disease is primary progressive multiple sclerosis.